SCHEMBL7732490

SCHEMBL7732490

O=[N+]([O-])C(Br)c1ccccc1Br

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.40
IDO1 P14902 1/20 0.35
TDO2 P48775 1/20 0.35
ALDH1A1 P00352 9/20 0.35
HPGD P15428 2/20 0.35
HIF1A Q16665 1/20 0.35
HTT P42858 1/20 0.34
LMNA P02545 3/20 0.33
CYP2C9 P11712 2/20 0.33
CYP2C19 P33261 2/20 0.33
CTSB P07858 1/20 0.33
PDE7A Q13946 4/20 0.33
TP53 P04637 1/20 0.32
GAA P10253 1/20 0.32
PDE7B Q9NP56 2/20 0.32
MAPT P10636 4/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
MAPK1 P28482 1/20 0.32
MEN1 O00255 1/20 0.31
NPC1 O15118 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8863993 0.78 HTT (0.40) CYP1A2IDO1TDO2ALDH1A1HTT
SCHEMBL1167742 0.78 CYP1A2 (0.59) CYP1A2ALDH1A1HIF1ACYP2C9CYP2C19
SCHEMBL3944521 0.78 GABRA1 (0.43) CYP1A2ALDH1A1HPGDHIF1ALMNA
SCHEMBL25308183 0.78 GABRA1 (0.43) CYP1A2ALDH1A1HPGDHIF1ALMNA
SCHEMBL23674864 0.73 GSR (0.38) CYP1A2IDO1TDO2ALDH1A1HPGD
SCHEMBL27937647 0.72 HTT (0.43) CYP1A2IDO1TDO2ALDH1A1HPGD
SCHEMBL446453 0.71 CES2 (0.43) CYP1A2ALDH1A1HPGDHIF1ALMNA
SCHEMBL23496048 0.70 GSR (0.35) CYP1A2ALDH1A1HPGDHTTLMNA
SCHEMBL23496050 0.70 GSR (0.35) CYP1A2ALDH1A1HPGDHTTLMNA
Bromide SCHEMBL29163778 0.70 NPC1 (0.42) CYP1A2ALDH1A1HPGDHIF1ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6407083-B1 ADMINISTERING AS 7-NITROBENZISOSELENAZOLINE DERIVATIVES AS ANTITUMOR AND ANTICARCINOGENIC AGENTS OXIS INTERNATIONAL, INC. 2002-06-18 US disclosed
US-6130212-A ANTITUMOR OXIS INTERNATIONAL S.A. (US) 2000-10-10 US disclosed
US-6057310-A TREATING LEUKEMIA, BREAST CANCER OXIS ISLE OF MAN, LIMITED (US) 2000-05-02 US disclosed
US-6001825-A Use of novel organoselenium compounds as pro-oxidizing agents their methods of preparation and pharmaceutical compositions and application thereof OXIS ISLE OF MAN, LIMITED (US) 1999-12-14 US disclosed
EP-0819682-A1 Use of novel organoselenium compounds as pro-oxidizing agents, their methods of preparation and pharmaceutical compositions and application containing them Oxis International S.A. (FR) 1998-01-21 EP disclosed